Adamas Pharmaceuticals Inc·4

May 18, 5:22 PM ET

Adamas Pharmaceuticals Inc 4

4 · Adamas Pharmaceuticals Inc · Filed May 18, 2015

Insider Transaction Report

Form 4
Period: 2015-05-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2015-05-14+19,00019,000 total
    Exercise: $17.97Exp: 2025-05-13Common Stock (19,000 underlying)
  • Sale

    Common Stock

    2015-05-15$17.85/sh1,000$17,85046,778 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from May 14, 2015, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_583265

    POA DOCUMENT